Koenig W - Search Results

1

Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention.

Ray KK, Gunn LH, Conde LG, Raal FJ, Wright RS, Gosselin NH, Leiter LA, Koenig W, Schwartz GG, Landmesser U; ORION investigators. Ray KK, et al. Among authors: koenig w. Atherosclerosis. 2024 Apr;391:117472. doi: 10.1016/j.atherosclerosis.2024.117472. Epub 2024 Feb 15. Atherosclerosis. 2024. PMID: 38447434 Free article. Clinical Trial.

2

Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials.

Landmesser U, Koenig W, Leiter LA, Raal FJ, Ray KK, Wright RS, Han J, Conde LG, Schwartz GG. Landmesser U, et al. Among authors: koenig w. Atherosclerosis. 2023 Dec;386:117354. doi: 10.1016/j.atherosclerosis.2023.117354. Epub 2023 Oct 18. Atherosclerosis. 2023. PMID: 38016401 Free article. Clinical Trial.

3

Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.

Leiter LA, Raal FJ, Schwartz GG, Koenig W, Ray KK, Landmesser U, Han J, Conde LG, Wright RS. Leiter LA, et al. Among authors: koenig w. Diabetes Obes Metab. 2024 May 17. doi: 10.1111/dom.15650. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38757725

4

PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial.

Koren MJ, Descamps O, Hata Y, Hengeveld EM, Hovingh GK, Ikonomidis I, Radu Juul Jensen MD, Langbakke IH, Martens FMAC, Søndergaard AL, Witkowski A, Koenig W. Koren MJ, et al. Among authors: koenig w. Lancet Diabetes Endocrinol. 2024 Mar;12(3):174-183. doi: 10.1016/S2213-8587(23)00325-X. Epub 2024 Feb 1. Lancet Diabetes Endocrinol. 2024. PMID: 38310920 Clinical Trial.

5

Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.

Zegura B, Keber I, Sebestjen M, Koenig W. Zegura B, et al. Among authors: koenig w. Atherosclerosis. 2003 May;168(1):123-9. doi: 10.1016/s0021-9150(03)00088-1. Atherosclerosis. 2003. PMID: 12732395 Clinical Trial.

6

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. Lancet. 2017 Oct 21;390(10105):1833-1842. doi: 10.1016/S0140-6736(17)32247-X. Epub 2017 Aug 27. Lancet. 2017. PMID: 28855077 Clinical Trial.

7

Plasma proteome association with coronary heart disease and carotid intima media thickness: results from the KORA F4 study.

Elhadad MA, Del C Gómez-Alonso M, Chen CW, Neumeyer S, Delerue T, Rathmann W, Näbauer M, Meisinger C, Kääb S, Seissler J, Graumann J, Koenig W, Suhre K, Gieger C, Völker U, Peters A, Hammer E, Waldenberger M. Elhadad MA, et al. Among authors: koenig w. Cardiovasc Diabetol. 2024 May 29;23(1):181. doi: 10.1186/s12933-024-02274-3. Cardiovasc Diabetol. 2024. PMID: 38811951 Free PMC article.

8

Prediction of Myocardial Infarction Using a Combined Generative Adversarial Network Model and Feature-Enhanced Loss Function.

Yu S, Han S, Shi M, Harada M, Ge J, Li X, Cai X, Heier M, Karstenmüller G, Suhre K, Gieger C, Koenig W, Rathmann W, Peters A, Wang-Sattler R. Yu S, et al. Among authors: koenig w. Metabolites. 2024 Apr 30;14(5):258. doi: 10.3390/metabo14050258. Metabolites. 2024. PMID: 38786735 Free PMC article.

9

Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial.

Wright RS, Raal FJ, Koenig W, Landmesser U, Leiter LA, Vikarunnessa S, Lesogor A, Maheux P, Talloczy Z, Zang X, Schwartz GG, Ray KK. Wright RS, et al. Among authors: koenig w. Cardiovasc Res. 2024 May 16:cvae109. doi: 10.1093/cvr/cvae109. Online ahead of print. Cardiovasc Res. 2024. PMID: 38753448

10

Prognostic Value of Cardiovascular Biomarkers in the Population.

Neumann JT, Twerenbold R, Weimann J, Ballantyne CM, Benjamin EJ, Costanzo S, de Lemos JA, deFilippi CR, Di Castelnuovo A, Donfrancesco C, Dörr M, Eggers KM, Engström G, Felix SB, Ferrario MM, Gansevoort RT, Giampaoli S, Giedraitis V, Hedberg P, Iacoviello L, Jørgensen T, Kee F, Koenig W, Kuulasmaa K, Lewis JR, Lorenz T, Lyngbakken MN, Magnussen C, Melander O, Nauck M, Niiranen TJ, Nilsson PM, Olsen MH, Omland T, Oskarsson V, Palmieri L, Peters A, Prince RL, Qaderi V, Vasan RS, Salomaa V, Sans S, Smith JG, Söderberg S, Thorand B, Tonkin AM, Tunstall-Pedoe H, Veronesi G, Watanabe T, Watanabe M, Zeiher AM, Zeller T, Blankenberg S, Ojeda F. Neumann JT, et al. Among authors: koenig w. JAMA. 2024 May 13:e245596. doi: 10.1001/jama.2024.5596. Online ahead of print. JAMA. 2024. PMID: 38739396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,113 results

Search Page